Primer: Lepu Biopharma (2157 HK) - Aug 2026
Lepu Biopharma is rapidly transitioning into a commercial-stage entity, driven by its recently approved anti-PD-1 antibody, Puyouheng, and the...
103 Views
𝛼SK or SearchENTITY
Lepu Biopharma (2157 HK)
Lepu Biopharma (2157 HK)
70
Analysis
Health Care • China
Lepu Biopharma Co. Ltd. is an innovation-driven biopharmaceutical company focused on discovering, developing, and commercializing drug candidates in anti-tumor targeted therapy and oncology immunotherapy. The company's pipeline includes ADCs, immunotherapies, and oncolytic virus drugs, with commercial products like Puyouheng and Meiyouheng. It was founded in 2018 and is headquartered in Shanghai, China.
morex